Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells

BACKGROUND: Curcumin derivative C086 (cur C086) is a potential chemotherapeutic agent for patients with osteosarcoma. In this study, the effects of cur C086 combined with cisplatin on the biological processes of osteosarcoma cells were investigated. MATERIAL/METHODS: In this study, expression of BMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xi, Huang, Yulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414526/
https://www.ncbi.nlm.nih.gov/pubmed/32734935
http://dx.doi.org/10.12659/MSM.924507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414526/
https://www.ncbi.nlm.nih.gov/pubmed/32734935
http://dx.doi.org/10.12659/MSM.924507

Ejemplares similares